Clinical Trial Update: Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic Dermatitis [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of VC005 in healthy subjects and patients with mild to moderate atopic dermatitis; the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• VC005

Snippet

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED